Provided by Tiger Trade Technology Pte. Ltd.

Cellectis SA

3.21
-0.1903-5.59%
Volume:4K
Turnover:13.57K
Market Cap:324.68M
PE:-4.96
High:3.23
Open:3.23
Low:3.21
Close:3.41
52wk High:5.48
52wk Low:2.35
Shares:101.00M
Float Shares:74.70M
Volume Ratio:0.39
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6479
EPS(LYR):-0.6740
ROE:-94.54%
ROA:-11.67%
PB:7.91
PE(LYR):-4.77

Loading ...

Nov 22, 2016

Report of foreign issuer

初步的报告
Nov 21, 2016

Report of foreign issuer

Nov 21, 2016

Report of foreign issuer

参与奥本海默生命科学峰会,纽约在Piper Jaffray & 28日年度医疗会议,纽约
Nov 15, 2016

Report of foreign issuer

Nov 15, 2016

Report of foreign issuer

Nov 15, 2016

Report of foreign issuer

宣布成功cGMP制造第二个产品的候选人:UCART123
Nov 15, 2016

Report of foreign issuer

Calyxt生产1200吨High-Oleic大豆在美国
Nov 08, 2016

Report of foreign issuer

Nov 08, 2016

Report of foreign issuer

宣布两个口头报告和一个在2016年灰年会海报
Oct 31, 2016

Report of foreign issuer

Oct 31, 2016

Report of foreign issuer

Oct 31, 2016

Report of foreign issuer

Calyxt生成健康High-Oleic Low-Linolenic大豆品种增加氧化稳定性和增强的保质期在BMC植物生物学文章可用
Oct 31, 2016

Report of foreign issuer

在纽约举办世界上第一个基因编辑吃饭
Oct 04, 2016

Report of foreign issuer

Oct 04, 2016

Report of foreign issuer

Oct 04, 2016

Report of foreign issuer

宣布9458439年美国专利发行美国专利8921332年2014年12月发布后两项专利的家人声称嵌合的基本使用限制性内切核酸酶基因编辑在任何类型的细胞
Oct 04, 2016

Report of foreign issuer

Calyxt扩大专利组合,包括广泛使用的技术,如CRISPR / Cas9,锌指核酸酶和TAL-effector核酸酶对植物基因编辑发布9458439年和8921332年现在美国专利
Sep 27, 2016

Report of foreign issuer

Sep 27, 2016

Report of foreign issuer

赢得2016年大多数欧洲生物技术创新的中小企业医疗奖
Sep 08, 2016

Report of foreign issuer